Literature DB >> 26549465

Implementation of the malaria candidate vaccine RTS,S/AS01.

Brian Greenwood1, Ogobara K Doumbo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26549465     DOI： 10.1016/S0140-6736(15)00807-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  A protocol for systematic review and meta-analysis of optimizing treatment for malaria.

Authors:  Renyan Zhang; Xing Dong; Junyao Wang; Ying Guo; Yong Dai
Journal:  Medicine (Baltimore)       Date:  2020-09-04       Impact factor: 1.889

2.  RTS,S/AS01 Malaria Vaccine Efficacy is Not Modified by Seasonal Precipitation: Results from a Phase 3 Randomized Controlled Trial in Malawi.

Authors:  Larry Han; Michael G Hudgens; Michael E Emch; Jonathan J Juliano; Corinna Keeler; Francis Martinson; Portia Kamthunzi; Gerald Tegha; Marc Lievens; Irving F Hoffman
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

3.  Asia-Pacific malaria is singular, pervasive, diverse and invisible.

Authors:  J Kevin Baird
Journal:  Int J Parasitol       Date:  2016-11-09       Impact factor: 3.981

4.  Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts.

Authors:  Sash Lopaticki; Annie S P Yang; Alan John; Nichollas E Scott; James P Lingford; Matthew T O'Neill; Sara M Erickson; Nicole C McKenzie; Charlie Jennison; Lachlan W Whitehead; Donna N Douglas; Norman M Kneteman; Ethan D Goddard-Borger; Justin A Boddey
Journal:  Nat Commun       Date:  2017-09-15       Impact factor: 14.919

5.  Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.

Authors:  Kavita Singh; Martin Burkhardt; Sofia Nakuchima; Raul Herrera; Olga Muratova; Apostolos G Gittis; Emily Kelnhofer; Karine Reiter; Margery Smelkinson; Daniel Veltri; Bruce J Swihart; Richard Shimp; Vu Nguyen; Baoshan Zhang; Nicholas J MacDonald; Patrick E Duffy; David N Garboczi; David L Narum
Journal:  Commun Biol       Date:  2020-07-24

6.  First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.

Authors:  Alfred B Tiono; Issa Nébié; Nicholas Anagnostou; Aboubacar S Coulibaly; Georgina Bowyer; Erika Lam; Edith C Bougouma; Alphonse Ouedraogo; Jean Baptist B Yaro; Aïssata Barry; Rachel Roberts; Tommy Rampling; Carly Bliss; Susanne Hodgson; Alison Lawrie; Amidou Ouedraogo; Egeruan Babatunde Imoukhuede; Katie J Ewer; Nicola K Viebig; Amidou Diarra; Odile Leroy; Philip Bejon; Adrian V S Hill; Sodiomon B Sirima
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

7.  Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.

Authors:  Julie Healer; Wilson Wong; Jennifer K Thompson; Wengqiang He; Richard W Birkinshaw; Kazutoyo Miura; Carol A Long; Vladislav Soroka; Teit Max Moscote Søgaard; Thomas Jørgensen; Willem A de Jongh; Christopher Weir; Ella Svahn; Peter E Czabotar; Wai-Hong Tham; Ivo Mueller; Paul N Barlow; Alan F Cowman
Journal:  Cell Microbiol       Date:  2019-04-24       Impact factor: 3.715

8.  Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming.

Authors:  Yenni Yusuf; Tatsuya Yoshii; Mitsuhiro Iyori; Kunitaka Yoshida; Hiroaki Mizukami; Shinya Fukumoto; Daisuke S Yamamoto; Asrar Alam; Talha Bin Emran; Fitri Amelia; Ashekul Islam; Hiromu Otsuka; Eizo Takashima; Takafumi Tsuboi; Shigeto Yoshida
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

9.  Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial.

Authors:  Victorine A Mensah; Sophie Roetynck; Ebrima K Kanteh; Georgina Bowyer; Amy Ndaw; Francis Oko; Carly M Bliss; Ya Jankey Jagne; Riccardo Cortese; Alfredo Nicosia; Rachel Roberts; Flavia D'Alessio; Odile Leroy; Babacar Faye; Beate Kampmann; Badara Cisse; Kalifa Bojang; Stephen Gerry; Nicola K Viebig; Alison M Lawrie; Ed Clarke; Egeruan B Imoukhuede; Katie J Ewer; Adrian V S Hill; Muhammed O Afolabi
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

Review 10.  malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.

Authors: 
Journal:  PLoS Med       Date:  2017-11-30       Impact factor: 11.069
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.